China Biotechnology Services (08037) has entered into a master cooperation agreement with Stella Pharma to jointly promote the development and commercialization of Steboronine in China.

Zhichun Financial APP news: China Biotechnology Services (08037) announced that its ongoing collaboration with Stella Pharma has entered a new phase. On August 11, 2026, the company, Pengbo (Hainan) Boron Neutron Medical Technology Co., Ltd. (Pengbo (Hainan)), and Stella Pharma signed a legally binding main cooperation agreement for the development and commercialization of Steboronine in China.